At Bellissima, peptide and advanced supportive therapies are offered as part of a thoughtful, integrative approach to age management, metabolic health, and recovery. These therapies are not intended to replace foundational medical care, but to complement and enhance personalized treatment plans when clinically appropriate.
Our approach mirrors how we practice hormone optimization and weight management—measured, evidence-informed, and individualized—never trend-driven or transactional.
Peptides and other advanced supportive therapies have gained attention for their potential roles in metabolic support, tissue repair, inflammation modulation, neurologic function, immune support, and overall vitality. When used appropriately and under medical supervision, they may provide meaningful benefit for select patients.
At Bellissima, these therapies are considered adjunctive tools, incorporated only when they align with a patient’s clinical picture, goals, and broader plan of care. They are not positioned as shortcuts or standalone solutions.
As with all care at Bellissima, recommendations begin with a comprehensive consultation. We review health history, symptoms, lifestyle factors, labs when indicated, and existing therapies to determine whether peptide or advanced supportive options are appropriate.
Rather than offering individual products or vials, peptide and advanced therapies at Bellissima are provided as part of curated treatment plans. These plans are intentionally designed to:
In addition to select peptide therapies, Bellissima may incorporate other evidence-informed supportive treatments such as NAD therapy, low-dose naltrexone (LDN), and methylene blue, when clinically appropriate. These options are considered within the context of the patient’s overall medical plan and used to support cellular health, neurologic function, inflammation balance, or metabolic resilience.
Progress is monitored over time, and treatment plans are adjusted based on response, tolerance, and evolving goals. This ensures therapies remain aligned with safety, effectiveness, and long-term sustainability consistent with our concierge model of care.
Because Bellissima operates as a concierge medical practice, we are able to provide close clinical oversight, continuity of care, and individualized adjustments without the constraints of traditional insurance-driven medicine. This structure supports intentional decision-making and higher-touch care.
Peptide and advanced supportive therapies at Bellissima are best suited for patients who:
These therapies may not be appropriate for individuals looking for:
